Distinct differences in the cannabinoid receptor binding in the brain of C57BL/6 and DBA/2 mice, selected for their differences in voluntary ethanol consumption

Journal of Neuroscience Research

Volumn 60, Issue 1, 2000, Pages 122-128

  Hungund, Baslingappa L ^a,b,c   Basavarajappa, Balapal S ^a  

^a New York Stt Psychiat Inst at NKI   (United States)

^b Columbia University ^*  (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

2 arachidonylglycerol; Anandamide; EtOH preference; Inbred strains; SR141716A

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ALCOHOL; ANANDAMIDE; CANNABINOID RECEPTOR; RIMONABANT;

ALCOHOL CONSUMPTION; ARTICLE; BINDING AFFINITY; BRAIN; BRAIN MEMBRANE; DRINKING BEHAVIOR; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DENSITY; SIGNAL TRANSDUCTION;

ALCOHOL DRINKING; ANIMALS; BINDING, COMPETITIVE; BRAIN; CANNABINOIDS; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; RADIOLIGAND ASSAY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SELECTION (GENETICS); SPECIES SPECIFICITY;

EID: 0034067080     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(20000401)60:1<122::AID-JNR13>3.0.CO;2-S     Document Type: Article

References (47)

1. Adams IB, Ryan W, Singer M, Thomas BF, Compton DR, Razdan RK, Martin BR. 1995. Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs. J Pharmacol Exp Ther 273:1172-1181.
2. Ameri A. 1999. The effects of cannabinoids on the brain. Prog Neurobiol 58:315-348.
3. Arnone M, Maruani J, Chaperon F, Thiebot M, Poncelet M, Soubrie P, Le Fur G. 1997. Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacol 132:104-106.
4. Basavarajappa BS, Cooper TB, Hungund BL. 1998a. Chronic ethanol administration down-regulates cannabinoid receptors in mouse brain synaptic plasma membrane. Brain Res 793:212-218.
5. Basavarajappa BS, Cooper TB, Hungund BL. 1998b. Effect of chronic ethanol exposure on mouse brain arachidonic acid specific phospholipase A2. Biochem Pharmacol 55:515-521.
6. Basavarajappa BS, Hungund BL. 1999a. Chronic ethanol increases the cannabinoid receptor agonist, anandamide and its precursor N-archidonyl phosphatidyl ethanolamine in SK-N-SH Cells. J Neurochem 72:522-528.
7. 35S] GTPγ S binding in synaptic plasma membrane from chronic ethanol exposed mouse. Brain Res 815:89-97.
8. Basavarajappa BS, Saito M, Cooper TB, Hungund BL. 1997. Activation of arachidonic acid-specitic phospholipase A2 in human neuroblastoma cells after chronic alcohol exposure: prevention by GM1 ganglioside. Alcohol Clin Exp Res 21:1199-1203.
9. Belknap JK, Crabbe JC, Young ER. 1993. Voluntary consumption of ethanol in 15 inbred mouse strains. Psychopharmacol (Berl) 112:503-510.
10. Brandt J, Butters N, Ryan C, Bayog R. 1983. Cognitive loss and recovery in long-term alcohol abusers. Arch Gen Psychiatry 40:435-442.
11. Breivogel CS, Sim LJ, Childers SR. 1997. Regional differences in cannabinoid receptor/G-protein coupling in rat brain. J Pharmacol Exp Ther 282:1632-1642.
12. Charness ME. 1989. Ethanol and opioid receptor signaling. Experientia 45:418-428.
13. Colombo G, Agabio R, Fa M, Guano L, Lobina C, Loche A, Reali R, Gessa G. 1998. Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716. Alcohol and Alcoholism 33:126-130.
14. Compton DR, Rice KC, De Costa BR, Razdan RK, Melvin LS, Johnson MR, Martin BR. 1993. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther 265:218-226.
15. Pe Waele JP, Gianoulakis C. 1997. Characterization of the mu and delta opioid receptors in the brain of the C57BL/6 and DBA/2 mice, selected for their differences in voluntary ethanol consumption. Alcohol Clin Exp Res 21:754-762.
16. Devane WA, Dysarz FAd, Johnson MR, Melvin LS, Howlett AC. 1988. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34:605-613.
17. Dewey WL. 1986. Cannabinoid pharmacology. Pharmacol Rev 38:151-178.
18. Fadda F, Rossetti ZL. 1998. Chronic ethanol consumption: from neuro-adaptation to neurodegeneration. Prog Neurobiol 56:385-431.
19. Felder CC, Veluza JS, Williams HL, Briley EM, Matsuda LA. 1992. Cannabinoid agonist stimulate both receptor- and nonreceptor-mediated signal trasduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol Pharmacol 42:838-845.
20. Forman SA, Righi DL, Miller KW. 1989. Ethanol increases agonist affinity for nicotinic receptors from Torpedo. Biochem Biophys Acta 987:95-103.
21. Gallate JE, McGregor IS. 1999. The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716. Psychopharmacol 142:302-308.
22. Gebhardt CA, Naeser MA, Butters N. 1984. Computerized measures of CT scans of alcoholics: thalamic region related to memory. Alcohol 1:133140.
23. George FR. 1993. Genetic models in the study of alcoholism and substance abuse mechanisms. Prog Neuropsychopharmacol Biol Psychiatry 17:345-361.
24. Gordon AS, Collier K, Diamond I. 1986. Ethanol regulation of adenosine receptor-stimulated cAMP levels in a clonal neural cell line: an in vitro model of cellular tolerance to ethanol. Proc Natl Acad Sci USA 83:2105-2108.
25. ing VC, Childers SR, Deadwyler SA. 1995. Role of cyclic AMP dependent protein kinase in cannabinoid receptor modulation of potassium "A-current" in cultured rat hippocampal neurons. Life Sci. 56:2081-2088.
26. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Cost BR, Rice KC. 1991. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 16:8057-8066.
27. 3H]-CP55,940 binding to the cannabinoid receptor in brain. DuPont Biotech Update 6:21-30.
28. Howlett AC, Qualy JM, Khachatrian LL. 1986. Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol Pharmacol 29:307-313.
29. Kakihana R, Brown DR, McClearn GE, Tabershaw IR. 1966. Brain sensitivity to alcohol in inbred mouse strains. Science 154:1574-1575.
30. Le AD, Ko J, Chow S, Quan B. 1994. Alcohol consumption by C57BL/6, BALB/c, and DBA/2 mice in a limited access paradigm. Pharmacol Biochem Behav 47:375-378.
31. Lovinger DM. 1989. Ethanol potentiation of 5-HT3 receptor-mediated ion current in NCB-20 neuroblastoma cells. Neurosci Lett 122:57-60.
32. Lovinger DM, White G, Weight FF. 1989. Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 243:1721-1724.
33. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
34. Mackie K, Hille B. 1992. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci U S A 89:3825-3829.
35. Matsuda LA, Lolait MJ, Brownstein AL, Young AL, Bonner TI. 1990. Structure of a cannabinol receptors and functional expression of the cloned cDNA. Nature 346:561-564.
36. Ng GY, George SR. 1994. Dopamine receptor agonist reduces ethanol self-administration in the ethanol-preferring C57BL/6J inbred mouse. Eur J Pharmacol 269:365-374.
37. Rodriguez de Fonseca F, Gorriti MA, Fernandez-Ruiz JJ, Palomo T, Ramos JA. 1994. Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment. Pharmacol Biochem Behav 47:33-40.
38. Romero J, Garcia L, Fernandez-Ruiz JJ, Cebeira M, Ramos JA. 1995. Changes in rat brain cannabinoid binding sites after acute and chronic exposure to their endogenous agonist, anandamide, or to Δ9-tetrahydrocannabinol. Pharmacol Biochem Behav 51:731-737.
39. Rubino T, Patrini G, Parenti M, Massi P, Parolaro D. 1997. Chronic treatment with a synthetic cannabinoid CP-55,940 alters G-protein expression in the rat central nervous system. Mol Brain Res 44:191-197.
40. Ryan C, Butters N. 1989. Learning and memory impairments in young and old alcoholics: evidence for the premature-aging hypothesis. Alcohol Clin Exp Res 4:288-293.
41. Sim LJ, Selley DE, Xiao R, Childers SR. 1996. Differences in G-protein activation by mu- and delta-opioid, and cannabinoid, receptors in rat striatum. Eur J Pharmacol 307:97-105.
42. Suzdak PD, Schwartz RD, Skolnick P, Paul SM. 1986. Ethanol stimulates γ-aminobutyric acid receptor mediated chloride transport in rat brain synaptoneurosomes. Proc Natl Acad Sci USA 83:4071-4075.
43. Ticku MK. 1979. Differences in gama-aminobutyric acid receptor sensitivity in inbred strains of mice. J Neurochem 33:1135-1138.
44. Westlake TM, Howlett AC, Ali SF, Paule MC, Scallet AC, Slikker WJ. 1991. Chronic exposure to delta 9-tetrahydrocannabinol fails to irreversibly alter brain cannabinoid receptors. Brain Res 544:145-149.
45. Williams RJ, Veale MA, Horne P, Kelly E. 1993. Ethanol differentially regulates guanine nucleotide-binding protein alpha subunit expression in NG108-15 cells independently of extracellular adenosine. Mol Pharmacol 43:158-166.
46. Winkler A, Spanagel R. 1998. Differences in the kappa opioid receptor mRNA content in distinct brain regions of two inbred mice strains. Neuroreport 9:1459-1464.
47. Yasuda K, Raynor K, Kong H, Breder CD, Takeda J, Reisine T, Bell GI. 1993. Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proc Natl Acad Sci USA 90:6736-6740.